Skip to main content
Erschienen in: Journal of Parasitic Diseases 3/2015

01.09.2015 | Original Article

In vitro anti-Trichomonas vaginalis activity of Pistacia lentiscus mastic and Ocimum basilicum essential oil

verfasst von: Hayam Mohamed Ezz Eldin, Abeer Fathy Badawy

Erschienen in: Journal of Parasitic Diseases | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis; a cosmopolitan sexually transmitted disease. Metronidazole is the drug of choice for T. vaginalis infections. The increase in metronidazole resistant parasites and undesirable side effects of this drug makes the search for an alternative a priority for the management of trichomoniasis. Pistacia lentiscus mastic and Ocimum basilicum oil are known for their antibacterial, antifungal, antiviral and antiprotozoal effects. The present study was carried out to investigate the in vitro effects of P. lentiscus mastic and O. basilicum oil on T. vaginalis trophozoites. The effects of different concentrations of P. lentiscus mastic (15, 10 and 5 mg/ml) and different concentrations of O. basilicum oil (30, 20 and 10 μg/ml) on multiplication of trophozoites at different time points (after 24, 48, 72 and 96 h) were determined, also morphological changes were reported by transmission electron microscopy (TEM). The results showed that both plants caused an inhibition of growth of T. vaginalis trophozoites. The minimal lethal concentration of P. lentiscus mastic was 15 mg/ml after 24 h incubation, 10 mg/ml after 48 h and 5 mg/ml after 96 h. The minimal lethal concentration of O. basilicum oil was 30 μg/ml after 24 h incubation, 20 μg/ml after 48 h and 10 μg/ml after 96 h. TEM study of trophozoites treated by P. lentiscus mastic or by O. basilicum oil showed considerable damage of the membrane system of the trophozoites, and extensive vacuolization of the cytoplasm. These results highly suggest that P. lentiscus mastic and O. basilicum oil may be promising phytotherapeutic agents for trichomoniasis treatment.
Literatur
Zurück zum Zitat Adebajo AC, Ayoola OF, Iwalewa EO, Akindahunsi AA, Omisore NOA, Adewunmi CO, Adenowo TK (2006) Anti-trichomonal, biochemical and toxicological activities of methanolic extract and some carbazole alkaloids isolated from the leaves of Murraya koenigii growing in Nigeria. Phytomedicine 13(4):246–254. doi:10.1016/j.phymed.2004.12.002 CrossRefPubMed Adebajo AC, Ayoola OF, Iwalewa EO, Akindahunsi AA, Omisore NOA, Adewunmi CO, Adenowo TK (2006) Anti-trichomonal, biochemical and toxicological activities of methanolic extract and some carbazole alkaloids isolated from the leaves of Murraya koenigii growing in Nigeria. Phytomedicine 13(4):246–254. doi:10.​1016/​j.​phymed.​2004.​12.​002 CrossRefPubMed
Zurück zum Zitat Ali NM (2007) In vitro activity of commercially available Egyptian propolis on Trichomonas vaginalis. N Egypt J Med 36:7–15 Ali NM (2007) In vitro activity of commercially available Egyptian propolis on Trichomonas vaginalis. N Egypt J Med 36:7–15
Zurück zum Zitat Ansari S, Siddiqui AN (2012) Pistacia lentiscus: a review on phytochemistry and pharmacological properties. Int J Pharm Sci 4(4):16–20 Ansari S, Siddiqui AN (2012) Pistacia lentiscus: a review on phytochemistry and pharmacological properties. Int J Pharm Sci 4(4):16–20
Zurück zum Zitat Arthan D, Sithiprom S, Thima K, Limmatvatirat C, Chavalitshewinkoon-Petmitr P, Svasti J (2008) Inhibitory effects of Thai plants β-glycosides on Trichomonas vaginalis. Parasitol Res 103(2):443–448. doi:10.1007/s00436-008-0996-2 CrossRefPubMed Arthan D, Sithiprom S, Thima K, Limmatvatirat C, Chavalitshewinkoon-Petmitr P, Svasti J (2008) Inhibitory effects of Thai plants β-glycosides on Trichomonas vaginalis. Parasitol Res 103(2):443–448. doi:10.​1007/​s00436-008-0996-2 CrossRefPubMed
Zurück zum Zitat Balan KV, Prince J, Han Z, Dimas K, Cladaras M, Wyche JH, Sitaras NM, Pantazis P (2007) Antiproliferative activity and induction of apoptosis in human colon cancer cells treated in vitro with constituents of a product derived from Pistacia lentiscus L. Phytomedicine 14:263–272CrossRefPubMed Balan KV, Prince J, Han Z, Dimas K, Cladaras M, Wyche JH, Sitaras NM, Pantazis P (2007) Antiproliferative activity and induction of apoptosis in human colon cancer cells treated in vitro with constituents of a product derived from Pistacia lentiscus L. Phytomedicine 14:263–272CrossRefPubMed
Zurück zum Zitat Barbosa E, Calzada F, Campos R (2007) In vivo antigiardial activity of three flavonoids isolated from some medicinal plants used in Mexican traditional medicine for the treatment of diarrhea. J Ethnopharmacol 109(3):552–554CrossRefPubMed Barbosa E, Calzada F, Campos R (2007) In vivo antigiardial activity of three flavonoids isolated from some medicinal plants used in Mexican traditional medicine for the treatment of diarrhea. J Ethnopharmacol 109(3):552–554CrossRefPubMed
Zurück zum Zitat Cedillo-Rivera R, Chavez B, Gonzalez-Robles A, Tapia A, Yepez-Mulia L (2002) In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites. J Eukaryot Microbiol 49:201–208CrossRefPubMed Cedillo-Rivera R, Chavez B, Gonzalez-Robles A, Tapia A, Yepez-Mulia L (2002) In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites. J Eukaryot Microbiol 49:201–208CrossRefPubMed
Zurück zum Zitat Cherpes T, Wiesenfeld H, Melan M, Kant JA, Consentino LA, Meyn LA, Hillier SL (2006) The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis 33:747–752CrossRefPubMed Cherpes T, Wiesenfeld H, Melan M, Kant JA, Consentino LA, Meyn LA, Hillier SL (2006) The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis 33:747–752CrossRefPubMed
Zurück zum Zitat Cotch MF, Pastorek JG, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG (1997) Trichomonas vaginalis associated with low birth weight and preterm delivery. The vaginal infections and prematurity study group. Sex Transm Dis 24:353–360CrossRefPubMed Cotch MF, Pastorek JG, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG (1997) Trichomonas vaginalis associated with low birth weight and preterm delivery. The vaginal infections and prematurity study group. Sex Transm Dis 24:353–360CrossRefPubMed
Zurück zum Zitat Diamond LS (1957) The establishment of various trichomonds of animals and man in axenic cultures. J Parasitol 43:488–490CrossRefPubMed Diamond LS (1957) The establishment of various trichomonds of animals and man in axenic cultures. J Parasitol 43:488–490CrossRefPubMed
Zurück zum Zitat Duarte M, Giordani RB, De Carli GA, Zuanazzi JA, Macedo AJ, Tasca T (2009) A quantitative resazurin assay to determinate the viability of Trichomonas vaginalis and the cytotoxicity of organic solvents and surfactant agents. Exp Parasitol 123:195–198. doi:10.1016/j.exppara.2009.07.002 CrossRefPubMed Duarte M, Giordani RB, De Carli GA, Zuanazzi JA, Macedo AJ, Tasca T (2009) A quantitative resazurin assay to determinate the viability of Trichomonas vaginalis and the cytotoxicity of organic solvents and surfactant agents. Exp Parasitol 123:195–198. doi:10.​1016/​j.​exppara.​2009.​07.​002 CrossRefPubMed
Zurück zum Zitat El-Sherbini GT, Shoukry NM (2012) In Vitro effect of pomegranate peel extract on Trichomonas tenax. Life Sci J 9(3):791–797 El-Sherbini GT, Shoukry NM (2012) In Vitro effect of pomegranate peel extract on Trichomonas tenax. Life Sci J 9(3):791–797
Zurück zum Zitat González-Coloma A, Reina M, Sáenz C, Lacret R, Ruiz-Mesia L, Arán VJ, Sanz J, Martínez-Díaz RA (2011) Antileishmanial, antitrypanosomal and cytotoxic screening of ethnopharmacologically selected Peruvian plants. Parasitol Res 110(4):1381–1392. doi:10.1007/s00436-011-2638-3 CrossRefPubMed González-Coloma A, Reina M, Sáenz C, Lacret R, Ruiz-Mesia L, Arán VJ, Sanz J, Martínez-Díaz RA (2011) Antileishmanial, antitrypanosomal and cytotoxic screening of ethnopharmacologically selected Peruvian plants. Parasitol Res 110(4):1381–1392. doi:10.​1007/​s00436-011-2638-3 CrossRefPubMed
Zurück zum Zitat Gradoni L, Ascenzi P (2004) Nitric oxide and anti-protozoan chemotherapy. Parasitologia 46(1–2):101–103 Gradoni L, Ascenzi P (2004) Nitric oxide and anti-protozoan chemotherapy. Parasitologia 46(1–2):101–103
Zurück zum Zitat Issazadeh K, Pahlaviani MR, Massiha A, Bidarigh S, Giahi M, Muradov PZ (2012) Analysis of the phytochemical contents and anti-microbial activity of Ocimum basilicum L. Int J Mol Clin Microbiol 1:141–147 Issazadeh K, Pahlaviani MR, Massiha A, Bidarigh S, Giahi M, Muradov PZ (2012) Analysis of the phytochemical contents and anti-microbial activity of Ocimum basilicum L. Int J Mol Clin Microbiol 1:141–147
Zurück zum Zitat Koba K, Poutouli PW, Christine RC, Sanda K (2009) Antifungal activity of the essential oils from Ocimum gratissimum L. grown in Togo. J Sci Res 1:164–171 Koba K, Poutouli PW, Christine RC, Sanda K (2009) Antifungal activity of the essential oils from Ocimum gratissimum L. grown in Togo. J Sci Res 1:164–171
Zurück zum Zitat Koo H, Gomes FA, Rosalen PL, Ambrosano GMB, Park YK, Cury JA (2000) In vitro antimicrobial activity of propolis and Arnica montana against oral pathogens. Arch Oral Biol 45:141–148CrossRefPubMed Koo H, Gomes FA, Rosalen PL, Ambrosano GMB, Park YK, Cury JA (2000) In vitro antimicrobial activity of propolis and Arnica montana against oral pathogens. Arch Oral Biol 45:141–148CrossRefPubMed
Zurück zum Zitat Li S, Cha I, Nam W (2011) Chios mastic gum extracts as a potent antitumor agent that inhibits growth and induces apoptosis of oral cancer cells. Asian Pac J Cancer Prev 12:1877–1880PubMed Li S, Cha I, Nam W (2011) Chios mastic gum extracts as a potent antitumor agent that inhibits growth and induces apoptosis of oral cancer cells. Asian Pac J Cancer Prev 12:1877–1880PubMed
Zurück zum Zitat Meri T, Jokiranta S, Suhonen L, Meri S (2000) Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations. J Clin Microbiol 38(2):763–767PubMedCentralPubMed Meri T, Jokiranta S, Suhonen L, Meri S (2000) Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations. J Clin Microbiol 38(2):763–767PubMedCentralPubMed
Zurück zum Zitat Oxberry ME, Thompson RCA, Reynoldson JA (1994) Evaluation of the effects of albendazole and metronidazole on the ultrastructure of Giardia duodenalis, Trichomonas vaginalis and Spironucleus muris using transmission electron microscopy. Int J Parasitol 24(5):695–703. doi:10.1016/0020-7519(94)90123-6 CrossRefPubMed Oxberry ME, Thompson RCA, Reynoldson JA (1994) Evaluation of the effects of albendazole and metronidazole on the ultrastructure of Giardia duodenalis, Trichomonas vaginalis and Spironucleus muris using transmission electron microscopy. Int J Parasitol 24(5):695–703. doi:10.​1016/​0020-7519(94)90123-6 CrossRefPubMed
Zurück zum Zitat Palmas C, Wakelin D, Gabriele F (1984) Transfer of immunity against Hymenolepis nana in mice with lymphoid cells or serum from infected donors. Parasitology 89(2):287–293CrossRefPubMed Palmas C, Wakelin D, Gabriele F (1984) Transfer of immunity against Hymenolepis nana in mice with lymphoid cells or serum from infected donors. Parasitology 89(2):287–293CrossRefPubMed
Zurück zum Zitat Rasolson M, Vanacova S, Tomkova E, Rezga J, Hardy IJ, Kulda J (2002) Mechanisms of in vitro development of resistance to metronidazole in Trichomonas vaginalis. Microbiology 148:2467–2477 Rasolson M, Vanacova S, Tomkova E, Rezga J, Hardy IJ, Kulda J (2002) Mechanisms of in vitro development of resistance to metronidazole in Trichomonas vaginalis. Microbiology 148:2467–2477
Zurück zum Zitat Sutcliffe S, Giovannucci E, Alderete JF, Chang TH, Gaydos CA, Zenilman JM, De Marzo AM, Willett WC, Platz EA (2006) Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15:939–945CrossRefPubMed Sutcliffe S, Giovannucci E, Alderete JF, Chang TH, Gaydos CA, Zenilman JM, De Marzo AM, Willett WC, Platz EA (2006) Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15:939–945CrossRefPubMed
Zurück zum Zitat Taran M, Azizi E, Shikhvaisi A, Asadi N (2009) The antihelmintic effect of Pistacia khinjuk against protoscoleces of Echinococcus granulosus. World J Zool 4(4):291–295 Taran M, Azizi E, Shikhvaisi A, Asadi N (2009) The antihelmintic effect of Pistacia khinjuk against protoscoleces of Echinococcus granulosus. World J Zool 4(4):291–295
Zurück zum Zitat Taran M, Mohebali M, Esmaeli J (2010) In vivo efficacy of gum obtained Pistacia atlantica in experimental treatment of cutaneous leishmaniasis. Iranian J Publ Health 39:36–41 Taran M, Mohebali M, Esmaeli J (2010) In vivo efficacy of gum obtained Pistacia atlantica in experimental treatment of cutaneous leishmaniasis. Iranian J Publ Health 39:36–41
Zurück zum Zitat Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen PL, Van de Wijgert J, Mmiro F, Mugerwa R, Chipato T, Morrison CS (2008) Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 197:548–554. doi:10.1086/526496 CrossRef Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen PL, Van de Wijgert J, Mmiro F, Mugerwa R, Chipato T, Morrison CS (2008) Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 197:548–554. doi:10.​1086/​526496 CrossRef
Zurück zum Zitat Viikki M, Pukkala E, Nieminen P, Hakama M (2000) Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol 39:71–75CrossRefPubMed Viikki M, Pukkala E, Nieminen P, Hakama M (2000) Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol 39:71–75CrossRefPubMed
Zurück zum Zitat World Health Organization (2011) Prevalence and incidence of selected sexually transmitted infections, Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates. WHO Press, Geneva World Health Organization (2011) Prevalence and incidence of selected sexually transmitted infections, Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates. WHO Press, Geneva
Metadaten
Titel
In vitro anti-Trichomonas vaginalis activity of Pistacia lentiscus mastic and Ocimum basilicum essential oil
verfasst von
Hayam Mohamed Ezz Eldin
Abeer Fathy Badawy
Publikationsdatum
01.09.2015
Verlag
Springer India
Erschienen in
Journal of Parasitic Diseases / Ausgabe 3/2015
Print ISSN: 0971-7196
Elektronische ISSN: 0975-0703
DOI
https://doi.org/10.1007/s12639-013-0374-6

Weitere Artikel der Ausgabe 3/2015

Journal of Parasitic Diseases 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.